RNAC · Cartesian Therapeutics, Inc. · Exempt Offerings
$7.10
-0.04 (-0.56%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$224.19M
Shares
30.26M
Volume · Oct 6
49.3K
Avg daily vol (3M)
132.69K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-07-17 | New | Biotechnology | $130,023,000 | $130,023,000 | 06b |
| 2023-12-04 | Amendment | Biotechnology | $60,250,000 | $60,250,000 | 06b |
| 2023-12-01 | New | Biotechnology | $60,250,000 | $60,250,000 | 06b |
| 2020-08-18 | New | Biotechnology | $25,000,000 | $25,000,000 | 06b |
| 2020-01-02 | New | Biotechnology | $70,000,000 | $70,000,000 | 06b |
Showing 1–5 of 5 filings